MBX Biosciences, Inc. (MBX): Price-to-Revenue Ratio

Corporate company logo of MBX Bio (MBX)

The prospects of MBX Biosciences Inc (MBX) depend on the outcomes of early peptide drug tests, supported by sufficient liquidity reserves. P/S volatility reflects the market valuation of revenue, with the metric holding around . The company's revenues will be based on therapies for endocrine pathologies and rare syndromes. Experienced management ensures strict cost control, focusing on achieving critical clinical milestones.

MBX Biosciences (MBX): Price-to-Revenue Ratio from 07/04/2022 to 11/13/2026

Metric breakdowns and analytics for MBX Bio (MBX)

- current quotes and average value forecast:
Market Price mbxbio.com|MBX - Price Target Chart
- stock exchange capitalization data:
Market Value MBX Bio|MBX - Enterprise Value
- issuer book value statistics:
Net Assets per Share MBX Biosciences|MBX - Company Book Value|Market Capitalization to Book Value mbxbio.com|MBX - Aggregate Company Assets
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio MBX Biosciences Inc|MBX - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio MBX Corp|MBX - Company Aggregate Debts|Debt to Book Capitalization Ratio MBX Bio|MBX - Company Long-Term Liabilities|Company Short-Term Indebtedness MBX Biosciences|Intermediate Coverage Ratio mbxbio.com
- net income and valuation ratios data:
MBX - Net Profit|Expected Profit MBX Biosciences Inc|MBX - P/E Multiple|Market Cap to Projected Earnings MBX Biosciences, Inc.|MBX - Price/Earnings to Growth Ratio|Company Value to EBITDA MBX Bio|MBX - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters MBX Biosciences|MBX - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months mbxbio.com|MBX - Earnings growth in current year|Consensus forecast of earnings per share growth for next year MBX Biosciences Inc
- total revenue and sales volume data:
MBX - Revenue and Sales Volume|Company Expected Sales Volume mbxbio.com|MBX - Price-to-Revenue Ratio|Market Cap to Projected Revenue MBX Bio
General company analysis:mbxbio.com MBX
Original product of MBX Biosciences Inc

The P/S ratio determines the market value of one dollar of revenue, allowing an investor to assess the extent of the premium paid for an asset's current sales. By analyzing the price-to-sales ratio dynamics on the GURU.Markets platform, one can see how the market prices in the uniqueness of the PEP platform and the high barriers to entry in the endocrine peptide sector for MBX Biosciences Inc (MBX), despite stringent FDA oversight.

Who MBX Biosciences Inc competes with

ASND - Price to Sales|Price-to-Revenue Ratio Madrigal Pharmaceuticals, Inc. MDGL|Corcept Therapeutics Inc. - Price-to-Revenue Ratio|Rhythm Pharmaceuticals Inc - P/S Multiple|Price-to-Revenue Coefficient Akero Corp AKRO|Metsera Inc (MTSR) - Price-to-Revenue Ratio|MLTX - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Crinetics|Market Cap to Revenue NewAmsterdam Pharma Company (NAMS)|Price-to-Revenue Ratio Soleno (SLNO)|Market Cap to Revenue Amicus Corp FOLD|P/S Multiple ETNB (89bio, Inc.)|agios.com - Price-to-Revenue Ratio|GPCR: Market Cap to Revenue|MDXG (MiMedx Group Inc) - Market Cap to Revenue Ratio|RZLT (Rezolute Corp) - Market Cap to Revenue|Lexicon Corp - Market Capitalization-to-Revenue Ratio|ALT (Altimmune, Inc.) - P/S Multiple|Price-to-Revenue Ratio AARD|P/S Multiple SGMT|Price-to-Revenue Coefficient BioAge Labs|Price-to-Revenue Ratio Biomea BMEA|Quince Therapeutics Inc (QNCX) - Price to Sales|GUTS - Price-to-Revenue Ratio|Price-to-Revenue Coefficient vTv Therapeutics Inc. VTVT|ATPC: P/S Multiple|Market Cap to Revenue Pluri|SYBX (Synlogic Inc.) - P/S Multiple|Lipocine Corporation (LPCN) - Price-to-Revenue Coefficient|P/S Multiple MTNB|SPRB - Price to Sales|Price-to-Revenue Ratio Galecto GLTO|CTCX: Market Cap to Revenue Ratio|Lumos Pharma Corp - P/S Multiple|Organovo Corp (ONVO) - Market Cap to Revenue|RDUS: P/S Multiple